A man who last month was given a “devastating diagnosis” of having less than six months to live asked a California judge to expedite his case against Monsanto, maker of the weed killer he claims made him sick. But Monsanto’s lawyers said the man’s terminal diagnosis is not grounds for moving up his trial date. Instead, he should be deposed, they said.
Emmanuel Richard Giglio is one of several people in a multidistrict litigation blaming Monsanto’s Roundup and Ranger Pro pesticides for their non-Hodgkin lymphoma diagnoses. They claim the active ingredient in the weed killers – glyphosate – is the culprit.
While the Environmental Protection Agency (EPA) does not consider glyphosate a likely cause of cancer, the World Health Organization’s International Agency for Research on Cancer (IARC) in 2015 said that the chemical is “probably carcinogenic to humans.”
Roundup was introduced by Monsanto in the mid-1970s. Its sales boomed two decades later when the company introduced genetically modified seeds that were resistant to glyphosate, allowing farmers to kill weeds without harming their crops. But lawsuits quickly followed, particularly by those who used the product the most, including groundskeepers, farmers and landscapers, who said the herbicides gave them cancer.
Monsanto was recently sold to Bayer AG.
In August, in a separate Roundup trial in California state court, a jury awarded a school groundskeeper $289 million after finding his regular use of Roundup and Ranger Pro caused him to develop non-Hodgkin lymphoma. The verdict was later reduced to $78 million.